Anthera Pharmaceuticals, Inc. (ANTH)

OTCMKTS: ANTH · Delayed Price · USD
0.0000
0.0000 (0.00%)
Jun 24, 2022 4:00 PM - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2017201620152014201320122011201020092008200720062005 2004 - 2003
Revenue
00.153.190000000000
Upgrade
Gross Profit
003.190000000000
Upgrade
Selling, General & Admin
7.9411.077.576.626.566.727.866.33.432.982.470.820.21
Upgrade
Research & Development
28.5946.5130.8621.8421.6849.2285.2829.468.4210.8823.927.760.35
Upgrade
Other Operating Expenses
-0.100000000000-0.01
Upgrade
Operating Expenses
36.4357.5838.4328.4628.2555.9393.1435.7611.8413.8626.398.580.55
Upgrade
Operating Income
-36.43-57.18-35.24-28.46-28.25-55.93-93.14-35.76-11.84-13.86-26.39-8.58-0.55
Upgrade
Interest Income
000000000.020.180.700
Upgrade
Interest Expense
0001.052.63.352.80.860.390.300.090.01
Upgrade
Other Expense / Income
9.561.650.02-1.15-2.61-3.470.61-3.80-4.120-0.10.01
Upgrade
Pretax Income
-26.87-55.52-35.22-29.6-30.86-59.400000-8.68-0.54
Upgrade
Net Income
-26.87-55.52-35.22-29.6-30.86-59.4-95.34-40.41-12.2-18.1-25.69-8.68-0.54
Upgrade
Shares Outstanding (Basic)
10543211000000
Upgrade
Shares Outstanding (Diluted)
10543211000000
Upgrade
EPS (Basic)
-2.86-12.88-7.92-10.88-13.52-65.92-163.20-112.64-79.36-765.33-1086.46-868.00-54.00
Upgrade
EPS (Diluted)
-2.86-12.88-7.92-10.88-13.52-65.92-163.20-112.64-79.36-765.33-1086.46-868.00-54.00
Upgrade
Free Cash Flow Per Share
-3.59-9.62-6.96-9.41-13.98-81.76-127.28-77.66
Upgrade
EBITDA
-45.79-55.26-34.94-28.12-27.89-55.6-93.66-31.94-11.82-9.72-26.37-8.59-0.53
Upgrade